Cardiology Symposium was held to present and share various case studies supported by clinical data about Ayurveda’s success in treating and reversing cardiac diseases.
The brand of Vaidya Sane Ayurved Laboratories through their Ayurvedic treatments and therapies, brought together about 5,000 doctors from across India for this virtual conference, which saw wide participation from the practitioners of modern medicine.
Addressing the participants, Dr Rohit Madhav Sane, MD & CEO, Madhavbaug, underscored the need for scientific evidence-based practise of Ayurveda to unleash its real potential, said “A major concern about ayurveda is the lack of an evidence-based approach in its treatment procedures. Any treatment method to stand the test of time should be scientifically proven. “We have taken a major initiative in that direction by developing a standard treatment protocol for over 100 disorders based on clinically validated data.”
In inaugural speech, Dr Madhuri Kanitkar, Lt. Gen (Retd), Vice Chancellor of Maharashtra University of Health Sciences (MUHA), recommended proper documentation of Ayurveda’s success in treating various illnesses.
Echoing a similar thought, Dr Jagdish Hiremath, Chair Professor, Madhavbaug Institute of Preventive Cardiology, chaired by Maharashtra University of Health Sciences, said a proper scientific record of various ayurvedic treatment therapies and drugs will help the industry to make a major mark at the global level.
The four-day virtual event witnessed around 82 ayurvedic cardiac specialists from Maharashtra, Gujarat, MP, UP, Karnataka, and Goa presenting their extraordinary and challenging case studies supported by clinical data about ayurvedic management of various cardiometabolic disorders.
Some of the case studies presented during the symposium were the role of Pranayama in Chronic Stable Angina; the role of Sasneha Virechana in Hypertension; the role of Vrana Upkrama in Diabetic Wound Management; the effect of Langhan in fluid retention in known cases of chronic heart failure; obesity management in patients with comorbidities; and the role of 800 cal low carbohydrate diet and herbal medicines in diabetes patients, among others.
0 Comments